ISEc69-Mediated Mobilization of the Colistin Resistance Gene mcr-2 in Escherichia coli. 2020

Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, China.

OBJECTIVE The emergence of mobile colistin resistance genes has compromised the efficacy of the last resort antibiotic, colistin, in clinical treatment. The mcr-2 gene was first identified in Belgium in association with the insertion sequence ISEc69. However, the molecular mechanisms of mcr-2 mobilization are not well understood. METHODS To further explore the mobilization of mcr-2 gene via ISEc69, we constructed a conjugative plasmid that carries an intact composite transposon Tn7052. Transposition assays were performed by conjugation, the transposition sites were characterized by arbitrary primed PCR and DNA sequencing. RESULTS In this study, we experimentally demonstrated that mcr-2 could be mobilized as a composite transposon Tn7052 and its transposition generated 8-bp AT-rich duplications in the host genome. CONCLUSIONS These results indicate that mcr-2 gene could be mobilized by ISEc69, the current investigations provide mechanistic insights in the transposition of mcr-2.

UI MeSH Term Description Entries

Related Publications

Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
June 2017, mBio,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
June 2022, Microbiology spectrum,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
July 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
June 2016, International journal of antimicrobial agents,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
July 2017, Antimicrobial agents and chemotherapy,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
August 2017, mBio,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
September 2020, Microbial drug resistance (Larchmont, N.Y.),
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
May 2016, Antimicrobial agents and chemotherapy,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
May 2016, International journal of antimicrobial agents,
Yu-Zhang He, and Teng-Fei Long, and Bing He, and Xing-Ping Li, and Gong Li, and Liang Chen, and Xiao-Ping Liao, and Ya-Hong Liu, and Jian Sun
May 2016, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!